1Davierwala PM, Maganti M, Yau T. Decreasing significance of left ventricular dysfunction and redo surgery in predicting CABG mortality: a 12 year study. J Thorac Cardiovasc Surg, 2003,126:1335-1344.
2Kirklin JK, Naftel DC, Bourge DC, et al. Evolving trends in risk profiles and causes of death after heart transplantation:a ten year multi-institutional study. J Thorac Cardiovasc Surg, 2003, 125:881-890.
3Martin J, Sarai K, Yoshitake M, et al. Successful orthotopic pig heart transplantation from non-heart-beating donors. J Heart Lung Transplant, 1999, 18:597-606.
4Martin J, Lutter G, Ihling C, et al. Myocardial viability 24 hours after orthotopic heart transplantation from non-heart-beating donors. J Thorac Cardiovasc Surg, 2003, 125:1217-1228.
5Parolari A, Rubini P, Cannata A, et al. Endothelial damage during myocardial preservation and storage. Ann Thorac Surg, 2002, 73:682-690.
6Billia F, Carter K, Rao V, et al. Transforming growth-factor expression is significantly lower in hearts preserved with blood/insulin versus crystalloid cardioplegia. J Heart Lung Transplant,2002, 21:918-922.
7Kirklin J, McGiffin D. Control of the inflammatory response in extended myocardial preservation of the donor heart. Ann Thorac Surg, 1999, 68:1978-1982.
8John R, Rajasinghe H, Itescu S, et al. Factors affecting long term survival (10 years) after cardiac transplantation in the eyclosporine era. J Am Coll Cardiol, 2001, 37:189-194.
